2 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Cozaar: new trials by email Literature Review of Cozaar trials Research Report on Cozaar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection? Losartan, Valsartan, Azilsartan - Covid19, SARS-CoV Infection | Phase 3 | Terminated | University of British Columbia | 341 | 2020-10-09 | 2023-02-16 |
| COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19 Losartan, Placebo - SARS-CoV-2 Infection | Phase 2 / Phase 3 | Terminated | Bassett Healthcare | 15 | 2020-04-06 | 2022-03-24 |
COVID-19 (2) · Coronavirus Infections (2) · Acute Kidney Injury (1) · Respiratory Distress Syndrome (1) · Severe Acute Respiratory Syndrome (1) · Shock (1)
Bassett Healthcare (1) · University of British Columbia (1)
Canada (1) · France (1) · United States (1)
Daniel Freilich, MD (1) · James A Russell, MD (1) · Karen Tran, MD (1)